Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
48 hedge funds and large institutions have $10.6M invested in Singular Genomics Systems, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less funds holding
Funds holding: 62 → 48 (-14)
50% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 20
61% less capital invested
Capital invested by funds: $27.3M → $10.6M (-$16.7M)
93% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QM
QVIDTVM Management
The Woodlands,
Texas
|
+$736K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$94.8K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$38.3K |
| 4 |
WC
Weil Company
San Diego,
California
|
+$31K |
| 5 |
Renaissance Technologies
New York
|
+$27.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.53M |
| 2 |
Coatue Management
New York
|
-$1.39M |
| 3 |
DM
Deerfield Management
New York
|
-$908K |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$281K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$128K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OMC
51
Old Mission Capital
Chicago,
Illinois
| – | -$78.9K | -3,169 | Closed |
|
|
GCP
52
GSA Capital Partners
London,
United Kingdom
| – | -$62K | -2,503 | Closed |
|
|
E
53
Ergoteles
New York
| – | -$46.3K | -1,860 | Closed |
|
54
Charles Schwab
San Francisco,
California
| – | -$19.5K | -783 | Closed |
|
|
PMEF
55
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | -$16.2K | -652 | Closed |
|
56
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$16.2K | -649 | Closed |
|
57
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$13.4K | -538 | Closed |
|
58
Balyasny Asset Management
Chicago,
Illinois
| – | -$11.5K | -463 | Closed |
|
59
Point72 Asset Management
Stamford,
Connecticut
| – | -$6.17K | -248 | Closed |
|
|
CSS
60
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$5.06K | -203 | Closed |
|
|
CA
61
Clearstead Advisors
Cleveland,
Ohio
| – | -$1.25K | -50 | Closed |
|
62
Simplex Trading
Chicago,
Illinois
| – | -$595 | -32 | -84% |
|
63
New York State Common Retirement Fund
Albany,
New York
| – | -$422 | -17 | Closed |
|
OMIC Hedge Fund Activity: Q3 2023 in Review
48 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q3 2023, worth a combined $10.6M — down 61% from $27.3M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of OMIC and 1 opened new positions — a net loss of 14 holders — while 20 trimmed existing stakes and 10 added.
The largest buyer was QVIDTVM Management, opening a new position worth an estimated $736K. The largest seller was UBS Group, cutting an estimated $1.53M.
- 48 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q3 2023, down from 62 in Q2 2023.
- Funds reported $10.6M of Singular Genomics Systems, Inc. Common Stock stock for Q3 2023, down 61% quarter-over-quarter.
- 1 fund opened new Singular Genomics Systems, Inc. Common Stock positions in Q3 2023 and 15 closed out, a net change of -14 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q3 2023 was QVIDTVM Management, an estimated $736K added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q3 2023 was UBS Group, an estimated $1.53M sold.
Based on aggregated 13F filings for Q3 2023.